LifeMD, Inc. to Participate in Upcoming Investor Conferences
LifeMD, a direct-to-patient telehealth company, announced its participation in several upcoming conferences. Key details include:
- BTIG Digital Health Forum: Nov 21, 2022, at 1:00 PM EST, focusing on Virtual Primary Care and Health Services.
- Piper Sandler 34th Annual Healthcare Conference: Nov 29-Dec 1, 2022, with one-on-one meetings available.
- RHK Capital 2022 Disruptive Growth Conference: Dec 5-6, 2022, featuring presentations and individual meetings.
Live presentation links will be accessible on the company's investor webpage.
- None.
- None.
NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the following upcoming conferences:
BTIG Digital Health Forum
Date: | Nov 21, 2022 |
Format: | Presenting: Virtual Primary Care and Health Services |
Time: | 1:00 PM EST |
Registration: | Register here |
Piper Sandler 34th Annual Healthcare Conference
Date: | Nov 29-Dec 1, 2022 |
Format: | Available for one-on-one meetings Nov 29-Dec 1 |
RHK Capital 2022 Disruptive Growth Conference
Date: | Dec 5-6, 2022 |
Format: | Presenting; available for one-on-one meetings Dec 5-6 |
Time: | To be announced |
Registration: | Register here |
Links to the live presentations will be available on the investor portion of the company’s website, which can be found at https://ir.lifemd.com. A copy of the replay will be available for 90 days.
About LifeMD
LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.
Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
Company Contact
LifeMD, Inc.
Marc Benathen, CFO
marc@lifemd.com
FAQ
What is the date for LifeMD's participation in the BTIG Digital Health Forum?
When will LifeMD attend the Piper Sandler 34th Annual Healthcare Conference?
What are the dates for the RHK Capital 2022 Disruptive Growth Conference?
Is there a registration link for the upcoming LifeMD conferences?
What will LifeMD present at the conferences?
Where can I find the live presentations from LifeMD's conferences?
What is LifeMD's stock symbol?